Skip to main content
Therapeutic drug monitoring based on dasatinib dose optimization reduces PIEff incidence in CML
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Therapeutic drug monitoring based on dasatinib dose optimization reduces PIEff incidence in CML
User login
Username
Password
Reset your password
Concept
Lead
score
Chronic Myelogenous Leukemia
1
1
Tyrosine Kinase Inhibitor
0
0.91
Leukemia
0
0.76
Biologic Therapy
0
0.6
Antineoplastic Drug
0
0.38
Tyrosine Kinase
0
0.38
Specialty
Lead
score
Hematology-Oncology
1
1
Internal Medicine
0
1
Pharmacist
0
0.6